TransMedics Group, Inc. (TMDX) |
|
69.07 2.94 (4.45%)
|
01-27 16:00 |
|
Open: |
66.13 |
Pre. Close: |
66.13 |
|
High:
|
69.08 |
Low:
|
66.02 |
|
Volume:
|
305,475 |
Market Cap:
|
2,205(M) |
|
|
|
Technical analysis |
as of: 2023-01-27 4:48:34 PM |
|
Overall:
|
 |
| Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell. |
| Target: |
Six months: 80.68  One year: 94.24 |
| Support: |
Support1: 59.34 Support2: 53.33 |
| Resistance: |
Resistance1: 69.08 Resistance2: 80.68 |
| Pivot: |
62.13 |
| Moving Average: |
MA(5): 67.13 MA(20): 60.99
MA(100): 53.57 MA(250): 38.88 |
| MACD: |
MACD(12,26): 2.5 Signal(9): 1.6 |
| Stochastic oscillator: |
%K(14,3): 91 %D(3): 90.6  |
| RSI: |
RSI(14): 66.3 |
| 52-week: |
High: 69.08 Low: 10 |
| Average Vol(K): |
3-Month: 367 (K) 10-Days: 373 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ TMDX ] has closed below upper band by 12.4%. Bollinger Bands are 66.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 4 days. This is a sign that the current trend might continue. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
69.11 - 69.46 |
69.46 - 69.8 |
|
Low:
|
65.24 - 65.58 |
65.58 - 65.93 |
|
Close:
|
68.5 - 69.06 |
69.06 - 69.63 |
|
Company Description |
|
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts. |
Headline News |
Sun, 29 Jan 2023
Quantbot Technologies LP Makes New Investment in TransMedics ... - MarketBeat
Wed, 25 Jan 2023
TransMedics Group, Inc. (NASDAQ:TMDX) Shares Sold by Truist ... - MarketBeat
Tue, 24 Jan 2023
TransMedics Group, Inc. (NASDAQ:TMDX) Given Consensus Rating ... - MarketBeat
Thu, 19 Jan 2023
12500 Shares in TransMedics Group, Inc. (NASDAQ:TMDX ... - MarketBeat
Mon, 16 Jan 2023
Is TransMedics Group (NASDAQ:TMDX) A Risky Investment? - Simply Wall St
Mon, 09 Jan 2023
3 Breakout Growth Stocks to Buy for the Long Haul - The Motley Fool
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Underperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Neutral |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Medical Devices |
| Shares Out. |
32 (M) |
| Shares Float |
31 (M) |
|
% Held by Insiders
|
3.8 (%) |
|
% Held by Institutions
|
94.3 (%) |
|
Shares Short
|
1,530 (K) |
|
Shares Short P.Month
|
2,120 (K) |
Stock Financials |
|
EPS
|
-1.7 |
|
EPS Est Next Qtl
|
0 |
|
EPS Est This Year
|
0 |
|
EPS Est Next Year
|
0 |
|
Book Value (p.s.)
|
5.88 |
|
Profit Margin (%)
|
-58.8 |
|
Operating Margin (%)
|
-50.2 |
|
Return on Assets (ttm)
|
-11.1 |
|
Return on Equity (ttm)
|
-31.7 |
|
Qtrly Rev. Growth
|
378.2 |
|
Gross Profit (p.s.)
|
0.66 |
|
Sales Per Share
|
2.24 |
|
EBITDA (p.s.)
|
-1.05 |
|
Qtrly Earnings Growth
|
0 |
|
Operating Cash Flow
|
-48 (M) |
|
Levered Free Cash Flow
|
-45 (M) |
Stock Valuations |
|
PE Ratio
|
-40.87 |
|
PEG Ratio
|
0 |
|
Price to Book value
|
11.74 |
|
Price to Sales
|
30.72 |
|
Price to Cash Flow
|
-45.53 |
Stock Dividends |
|
Dividend
|
0 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
Invalid DateTime. |
|
Your Ad Here
|
|
